Tobam Penumbra Inc Transaction History

Tobam

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	BUY	$271.54 - $344.06 $46,433 - $58,834	171 New	171 $59,000
Q2 2022 Aug 02, 2022	SELL	$116.09 - $227.33 $6,965 - $13,639	-60 Closed	0 $0
Q1 2022 Apr 25, 2022	SELL	$187.51 - $283.98 $74,628 - $113,024	-398 Reduced 86.9%	60 $13,000
Q3 2021 Nov 12, 2021	SELL	$250.72 - $291.24 $164,221 - $190,762	-655 Reduced 58.85%	458 $122,000
Q2 2021 Aug 11, 2021	BUY	$235.0 - $310.7 $73,790 - $97,559	314 Added 39.3%	1,113 $305,000
Q1 2021 May 11, 2021	BUY	$175.6 - $291.43 $140,304 - $232,852	799 New	799 $216,000

370

29.1M

220K

158K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.01B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

Stay updated on Tobam with notifications on news.